Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Transforming Molecular Diagnostics through NanoTechnology

Objetivo

Biotechnology startup Altratech Ltd was founded with the vision to transform molecular diagnostics through nanotechnology. We
have developed and patented a novel technology for molecular testing of viruses and pathogens in non-clinical environments. This
all-synthetic novel assay can detect and quantify DNA, RNA, Antibody, and Antigen molecular targets, from blood or saliva samples, in
20 mins, without any need of centrifuges or pipettes. This will enable market-disrupting products that have the simplicity of a
pregnancy test and the performance of a laboratory PCR test.
All molecular diagnostic systems today require biological amplification, i.e. polymerase chain reaction (PCR), Loop-mediated
polymerase amplification (LAMP), or similar. This takes time, and requires trained personnel, refrigeration for enzymes, and specialised
equipment for heating/cooling and optical detection. It is because of these requirements that there is no solution on the market
today for the non-clinical detection, monitoring, and management of viral infections such as HIV, Hepatitis, Influenza, Malaria,
Meningitis, Shingles, Dengue Fever, HPV, EBV-related cancers, and many more.
Our solution is a molecular detection process that eliminates the requirement for biological amplification and optical detection. We
have invented and patented the key breakthrough of detecting and quantifying genetic material, viruses, and pathogens using
almost instant electronic signal amplification, with semiconductor sensing and digital readout.
The Value Proposition to our target customers, who will be the worlds leading diagnostic companies, is the ability to licence a novel
patent protected product, with a wider range of market applications compared to their current diagnostic products. This will
facilitate their entry into new markets and increase gross margins in existing markets.
This innovation will impact the 48B Diagnostics industry.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2024-ACCELERATOR-02

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

ALTRATECH LIMITED
Aportación neta de la UEn
€ 2 499 999,00
Dirección
4TH FLOOR 103/104 O CONNELL STREET
V94 AT85 Limerick
Irlanda
Pyme
Sí
Región
Ireland Southern Mid-West
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos